RecruitingPhase 1NCT06506461
Gene Editing For Sickle Cell Disease
Studying Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Akshay Sharma, MBBS, MScSt. Jude Children's Research Hospital
- Intervention
- Plerixafor(drug)
- Enrollment
- 25 target
- Eligibility
- 18-24 years · All sexes
- Timeline
- 2025 – 2032
Study locations (1)
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06506461 on ClinicalTrials.govOther trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07217548Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease PatientsOhio State University
- RECRUITINGPHASE2NCT07236190Biomarker-based Trial of NPC-1 for Alzheimer's PathologyMassachusetts General Hospital
- RECRUITINGPHASE1NCT06911008MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid CancersMayo Clinic
- ENROLLING BY INVITATIONNCT07331831Research on Attitudes, Confidence, and Practical Skills in Performing Cardiopulmonary Resuscitation and Automated External Defibrillation After Completing a Course Based on the European Resuscitation Council ModelFirst Three Minutes Foundation
- RECRUITINGNANCT07084142Developing a Digital Aid to Improve ICD DecisionsStanford University
- RECRUITINGNANCT06896825Increasing Physical Activity Through Social Support and Stress ResilienceArizona State University
- RECRUITINGNANCT07563660FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))Istanbul University - Cerrahpasa
- RECRUITINGNANCT06771700S-ICD Implantation: US Based Pilot StudyUniversitätsklinikum Köln
See all trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome →